ALZCHEM GROUP AG INH O.N.
ALZCHEM GROUP AG INH O.N./ DE000A2YNT30 /
ACT/D
13/11/2024 17:40:12
|
Chg.
+2.0000
|
Volume |
Bid20:45:46 |
Demandez à20:45:46 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
55.6000EUR
|
+3.73%
|
59 Chiffrre d'affaires: 3,282.8000 |
56.2000Bid taille: 100 |
56.6000Ask la taille: 100 |
565.8 Mio.EUR |
1.89% |
16.35 |
Description de l'entreprise
AlzChem AG, located in Trostberg, Bavaria, is a vertically integrated manufacturer of various chemical products based on the NCN chain. These are products with typical nitrogen-carbon-nitrogen bonding, which are used in a variety of industries. The company has a leading market position in selected niche markets, including the markets for feed additives and food supplements. The strategic focus of growth and the focus of the extensive research and development lie on the business segment Specialty Chemicals. The joint production and the brand portfolio protect AlzChem from potential market entries.
Conseil d'administration & Conseil de surveillance
PDG |
Andreas Lösler |
Conseil d'administration |
Andreas Niedermaier, Klaus Englmaier, Dr. Georg Weichselbaumer |
Conseil de surveillance |
Markus Zöllner, Prof. Dr. Martina Heigl-Murauer, Steve Röper, Dr. Caspar Freiherr von Schnurbein |
Données de l'entreprise
Nom: |
AlzChem Group AG |
Adresse: |
Chemiepark Trostberg, Dr.-Albert-Frank-Str. 32,D-83308 Trostberg |
Téléphone: |
+49-8621-86-0 |
Fax: |
+49-8621-86-2911 |
Courriel: |
info@alzchem.com
|
Internet: |
https://www.alzchem.com/ |
Industrie: |
Commodities |
Secteur: |
Chemicals |
Sous-secteur: |
Chemicals, diversified |
Fin de l'exercice financier: |
31/12 |
Flotte libre: |
50.35% |
IPO date: |
01/06/1999 |
Relations avec les investisseurs
Nom: |
Sabine Sieber |
Téléphone IR: |
+49-8621-86-2888 |
IR-Fax: |
- |
E-mail IR: |
ir@alzchem.com
|
Calendrier de l'entreprise
CW 9 | 28/02/2025
4th Quarter/Annual Report
|
CW 18 | 30/04/2025
Interim Report 1st Quarter/3 Months
|
CW 31 | 30/07/2025
Interim Report 2nd Quarter/6 Months
|
CW 44 | 30/10/2025
Interim Report 3rd Quarter/9 Months
|